6869 Stock Overview
Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 6869 from our risk checks.
Sysmex Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥3,171.00 |
52 Week High | JP¥3,236.00 |
52 Week Low | JP¥2,138.00 |
Beta | 0.63 |
11 Month Change | 12.47% |
3 Month Change | 17.27% |
1 Year Change | 18.70% |
33 Year Change | -34.33% |
5 Year Change | 26.92% |
Change since IPO | 3,071.00% |
Recent News & Updates
Estimating The Fair Value Of Sysmex Corporation (TSE:6869)
Nov 23Results: Sysmex Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 10Here's Why Sysmex (TSE:6869) Can Manage Its Debt Responsibly
Nov 03Does Sysmex (TSE:6869) Deserve A Spot On Your Watchlist?
Oct 21Recent updates
Estimating The Fair Value Of Sysmex Corporation (TSE:6869)
Nov 23Results: Sysmex Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 10Here's Why Sysmex (TSE:6869) Can Manage Its Debt Responsibly
Nov 03Does Sysmex (TSE:6869) Deserve A Spot On Your Watchlist?
Oct 21Sysmex's (TSE:6869) Returns On Capital Not Reflecting Well On The Business
Sep 18After Leaping 26% Sysmex Corporation (TSE:6869) Shares Are Not Flying Under The Radar
Sep 04Sysmex Corporation Just Recorded A 7.1% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 08A Look At The Intrinsic Value Of Sysmex Corporation (TSE:6869)
Jul 27Sysmex Corporation's (TSE:6869) Business Is Yet to Catch Up With Its Share Price
Jun 12Results: Sysmex Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
May 12These 4 Measures Indicate That Sysmex (TSE:6869) Is Using Debt Reasonably Well
Apr 27Sysmex Corporation's (TSE:6869) P/E Is On The Mark
Feb 28Shareholder Returns
6869 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | 0% | 1.0% | 1.8% |
1Y | 18.7% | 17.3% | 14.0% |
Return vs Industry: 6869 exceeded the JP Medical Equipment industry which returned 15.6% over the past year.
Return vs Market: 6869 exceeded the JP Market which returned 12.6% over the past year.
Price Volatility
6869 volatility | |
---|---|
6869 Average Weekly Movement | 3.7% |
Medical Equipment Industry Average Movement | 3.7% |
Market Average Movement | 3.7% |
10% most volatile stocks in JP Market | 7.4% |
10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 6869 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 6869's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1968 | 10,042 | n/a | www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Sysmex Corporation Fundamentals Summary
6869 fundamental statistics | |
---|---|
Market cap | JP¥1.98t |
Earnings (TTM) | JP¥53.46b |
Revenue (TTM) | JP¥491.29b |
37.0x
P/E Ratio4.0x
P/S RatioIs 6869 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
6869 income statement (TTM) | |
---|---|
Revenue | JP¥491.29b |
Cost of Revenue | JP¥228.51b |
Gross Profit | JP¥262.78b |
Other Expenses | JP¥209.32b |
Earnings | JP¥53.46b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) | 85.73 |
Gross Margin | 53.49% |
Net Profit Margin | 10.88% |
Debt/Equity Ratio | 7.1% |
How did 6869 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield34%
Payout RatioDoes 6869 pay a reliable dividends?
See 6869 dividend history and benchmarksSysmex dividend dates | |
---|---|
Ex Dividend Date | Mar 28 2025 |
Dividend Pay Date | Jun 24 2025 |
Days until Ex dividend | 112 days |
Days until Dividend pay date | 200 days |
Does 6869 pay a reliable dividends?
See 6869 dividend history and benchmarks